Chin filler retreatment under safety spotlight
NCT ID NCT07566286
First seen May 13, 2026 · Last updated Jun 22, 2026 · Updated 7 times
Summary
This study will check the safety of using Restylane Lyft with Lidocaine, a hyaluronic acid gel, for a second treatment to improve chin shape. About 100 adults aged 22 and older will receive the retreatment. The main goal is to see if any side effects occur within 3 months after the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIN AUGMENTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Galderma Investigational Site # 7030
Coral Gables, Florida, 33134, United States
Contact
-
Galderma Investigational Site # 7042
Atlanta, Georgia, 30331, United States
Contact
-
Galderma Investigational Site # 7043
Bethesda, Maryland, 20852, United States
Contact
-
Galderma Investigational Site # 7118
Nashville, Tennessee, 37203, United States
-
Galderma Investigational Site # 8662
Spring, Texas, 77388, United States
Contact
-
Galderma Investigational Site # 8680
Westport, Connecticut, 06880, United States
Contact
-
Galderma Investigational Site # 8682
Coral Gables, Florida, 33134, United States
Contact
-
Galderma Investigational Site # 8774
Boynton Beach, Florida, 33437, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Restylane Lyft with Lidocaine (hyaluronic acid gel)
What this could lead to
If successful, this could confirm that retreating the chin with this filler is safe for improving chin shape.
What could go wrong
This is a small, early-stage safety study with no comparison group. It does not test effectiveness, and results may not apply to everyone. Risks include allergic reactions or injection-site issues.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.